Cancer Care of Louisiana   /   Specialists in Cancer and Blood Disorders   /   cancercareofla.com   /   Careers   /   Home

Clinical Trials

GI Carcinoma

Phase 2 Open-label Multi-Center Study to Evaluate the Efficacy and Safety of AMG 386 and Sorafenib as First Line Therapy for Subjects with Advanced or Inoperable Hepatocellular Carcinoma.

  • Principal Investigator:  Thomas Cosgriff, M.D.

« Return to Previous Page

Clinical Trials Involve Years
of Research & Experiments

Carefully conducted clinical trials are the fastest and safest ways to find treatments that work in people and to improve health.

Copyright © 2012 Cancer Care of Louisiana. All Rights Reserved. Notice of Privacy Practices & Acknowledgement Form
*Cancer Care of LA is a trade name of Hematology & Oncology Specialists, LLC

Website By: Mudbug Media